Medtronic EBIT Margin 2010-2024 | MDT
Medtronic EBIT Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM EBIT | EBIT Margin |
2024-01-31 | $32.32B | $5.66B | 17.51% |
2023-10-31 | $31.96B | $5.57B | 17.42% |
2023-07-31 | $31.56B | $5.63B | 17.84% |
2023-04-30 | $31.23B | $5.49B | 17.56% |
2023-01-31 | $30.77B | $5.59B | 18.17% |
2022-10-31 | $30.81B | $5.86B | 19.01% |
2022-07-31 | $31.07B | $6.02B | 19.37% |
2022-04-30 | $31.69B | $5.75B | 18.16% |
2022-01-31 | $31.79B | $5.69B | 17.89% |
2021-10-31 | $31.80B | $5.30B | 16.68% |
2021-07-31 | $31.60B | $4.67B | 14.78% |
2021-04-30 | $30.12B | $4.48B | 14.89% |
2021-01-31 | $27.93B | $3.20B | 11.44% |
2020-10-31 | $27.87B | $3.56B | 12.77% |
2020-07-31 | $27.93B | $3.98B | 14.25% |
2020-04-30 | $28.91B | $4.79B | 16.57% |
2020-01-31 | $31.06B | $6.42B | 20.67% |
2019-10-31 | $30.89B | $6.32B | 20.47% |
2019-07-31 | $30.67B | $6.52B | 21.25% |
2019-04-30 | $30.56B | $6.27B | 20.51% |
2019-01-31 | $30.56B | $6.25B | 20.45% |
2018-10-31 | $30.38B | $6.14B | 20.23% |
2018-07-31 | $29.95B | $6.49B | 21.68% |
2018-04-30 | $29.95B | $6.64B | 22.17% |
2018-01-31 | $29.73B | $6.40B | 21.52% |
2017-10-31 | $29.64B | $6.11B | 20.60% |
2017-07-31 | $29.93B | $5.60B | 18.70% |
2017-04-30 | $29.71B | $5.38B | 18.12% |
2017-01-31 | $29.36B | $5.27B | 17.96% |
2016-10-31 | $29.01B | $5.48B | 18.90% |
2016-07-31 | $28.73B | $5.40B | 18.79% |
2016-04-30 | $28.83B | $5.36B | 18.59% |
2016-01-31 | $28.57B | $3.95B | 13.81% |
2015-10-31 | $25.95B | $3.87B | 14.89% |
2015-07-31 | $23.26B | $3.76B | 16.16% |
2015-04-30 | $20.26B | $3.77B | 18.59% |
2015-01-31 | $17.52B | $3.91B | 22.33% |
2014-10-31 | $17.37B | $3.66B | 21.09% |
2014-07-31 | $17.20B | $3.68B | 21.37% |
2014-04-30 | $17.01B | $3.81B | 22.42% |
2014-01-31 | $16.90B | $4.70B | 27.80% |
2013-10-31 | $16.76B | $4.89B | 29.18% |
2013-07-31 | $16.67B | $4.87B | 29.23% |
2013-04-30 | $16.59B | $4.76B | 28.66% |
2013-01-31 | $16.43B | $4.78B | 29.09% |
2012-10-31 | $16.32B | $4.71B | 28.89% |
2012-07-31 | $16.25B | $4.75B | 29.23% |
2012-04-30 | $16.18B | $4.75B | 29.34% |
2012-01-31 | $15.86B | $4.52B | 28.46% |
2011-10-31 | $15.80B | $4.51B | 28.54% |
2011-07-31 | $15.68B | $4.38B | 27.91% |
2011-04-30 | $15.51B | $4.30B | 27.71% |
2011-01-31 | $15.30B | $4.37B | 28.56% |
2010-10-31 | $15.30B | $4.49B | 29.36% |
2010-07-31 | $15.23B | $4.63B | 30.37% |
2010-04-30 | $15.39B | $4.71B | 30.63% |
2010-01-31 | $15.45B | $4.32B | 27.95% |
2009-10-31 | $15.09B | $4.03B | 26.71% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $106.730B | $31.227B |
Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $185.474B | 24.35 |
Stryker (SYK) | United States | $128.161B | 31.78 |
Boston Scientific (BSX) | United States | $106.966B | 34.07 |
EssilorLuxottica (ESLOY) | France | $99.574B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $42.648B | 0.00 |
Haleon (HLN) | United Kingdom | $38.127B | 29.82 |
ResMed (RMD) | United States | $27.032B | 27.03 |
Terumo (TRUMY) | Japan | $25.476B | 35.98 |
Zimmer Biomet Holdings (ZBH) | United States | $24.896B | 16.03 |
Baxter (BAX) | United States | $20.785B | 15.16 |
Koninklijke Philips (PHG) | Netherlands | $19.474B | 15.53 |
Insulet (PODD) | United States | $11.711B | 61.49 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.741B | 0.00 |
Demant (WILYY) | Denmark | $9.943B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $7.934B | 23.64 |
BellRing Brands (BRBR) | United States | $7.285B | 39.17 |
Lantheus Holdings (LNTH) | United States | $4.470B | 11.54 |
Haemonetics (HAE) | United States | $4.379B | 22.40 |
Perrigo (PRGO) | Ireland | $4.232B | 12.10 |
GN Store Nord (GNNDY) | Denmark | $3.937B | 25.50 |
Envista Holdings (NVST) | United States | $3.485B | 13.26 |
Prestige Consumer Healthcare (PBH) | United States | $3.482B | 16.46 |
QuidelOrtho (QDEL) | United States | $2.730B | 9.91 |
Neogen (NEOG) | United States | $2.679B | 25.77 |
Green Thumb Industries (GTBIF) | United States | $2.630B | 83.33 |
ICU Medical (ICUI) | United States | $2.357B | 17.58 |
TG Therapeutics (TGTX) | United States | $2.161B | 699.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.928B | 0.00 |
Owens & Minor (OMI) | United States | $1.895B | 18.19 |
Verano Holdings (VRNOF) | United States | $1.790B | 0.00 |
Agios Pharmaceuticals (AGIO) | United States | $1.780B | 0.00 |
InMode (INMD) | Israel | $1.458B | 7.55 |
LeMaitre Vascular (LMAT) | United States | $1.437B | 47.43 |
National Vision Holdings (EYE) | United States | $1.388B | 43.24 |
AdaptHealth (AHCO) | United States | $1.300B | 9.78 |
Warby Parker (WRBY) | United States | $1.287B | 0.00 |
AtriCure (ATRC) | United States | $1.115B | 0.00 |
MacroGenics (MGNX) | United States | $0.982B | 0.00 |
Canopy Growth (CGC) | Canada | $0.899B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.779B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.712B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.693B | 14.98 |
Evolus (EOLS) | United States | $0.666B | 0.00 |
Quanterix (QTRX) | United States | $0.613B | 0.00 |
Jin Medical (ZJYL) | China | $0.547B | 0.00 |
Valneva SE (VALN) | France | $0.540B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.509B | 11.02 |
PetIQ (PETQ) | United States | $0.487B | 18.17 |
TerrAscend (TSNDF) | Canada | $0.478B | 0.00 |
ZimVie (ZIMV) | United States | $0.430B | 26.35 |
OraSure Technologies (OSUR) | United States | $0.421B | 6.96 |
Biote (BTMD) | United States | $0.417B | 3.96 |
Aurora Cannabis (ACB) | Canada | $0.393B | 0.00 |
Surmodics (SRDX) | United States | $0.371B | 40.11 |
Zynex (ZYXI) | United States | $0.361B | 41.59 |
Viemed Healthcare (VMD) | United States | $0.314B | 31.11 |
Cerus (CERS) | United States | $0.301B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.280B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.274B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.241B | 14.70 |
Organigram Holdings (OGI) | Canada | $0.199B | 0.00 |
Veru (VERU) | United States | $0.193B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.192B | 0.00 |
Omeros (OMER) | United States | $0.176B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.163B | 0.00 |
High Tide (HITI) | Canada | $0.160B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.159B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.134B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.130B | 65.20 |
FitLife Brands (FTLF) | United States | $0.129B | 20.74 |
InterCure (INCR) | Israel | $0.122B | 20.54 |
Fonar (FONR) | United States | $0.102B | 8.80 |
Cellectar Biosciences (CLRB) | United States | $0.099B | 0.00 |
MariMed (MRMD) | United States | $0.097B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.096B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.088B | 0.00 |
Brainsway (BWAY) | Israel | $0.084B | 0.00 |
Safety Shot (SHOT) | United States | $0.081B | 0.00 |
Chimerix (CMRX) | United States | $0.081B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.060B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.059B | 3.86 |
Apyx Medical (APYX) | United States | $0.052B | 0.00 |
Cytosorbents (CTSO) | United States | $0.045B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
ImmuCell (ICCC) | United States | $0.039B | 0.00 |
United-Guardian (UG) | United States | $0.039B | 15.04 |
Bright Green (BGXX) | United States | $0.037B | 0.00 |
Modular Medical (MODD) | United States | $0.035B | 0.00 |
Exagen (XGN) | United States | $0.024B | 0.00 |
Nephros (NEPH) | United States | $0.023B | 0.00 |
Flora Growth (FLGC) | United States | $0.020B | 0.00 |
Agape ATP (ATPC) | $0.020B | 0.00 | |
FSD PHARMA (HUGE) | Canada | $0.018B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.010B | 72.54 |
NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Sharps Technology (STSS) | United States | $0.005B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.001B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |